세계의 휴대용 경두개 자극 장치 시장 보고서(2025년)
Portable Transcranial Stimulation Device Global Market Report 2025
상품코드 : 1877850
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,698,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,681,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,665,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

휴대용 경두개 자극 장치 시장 규모는 최근 급속히 확대되고 있습니다. 2024년의 12억 4,000만 달러로 평가되었고, 2025년에는 13억 7,000만 달러에 달하고, CAGR 10.2%로 성장할 것으로 전망되고 있습니다. 지난 몇 년간의 성장은 신경질환의 유병률 상승, 비침습적 뇌자극요법에 대한 인지도 향상, 재택치료 솔루션에 대한 수요 증가, 세계적인 정신건강 문제 증가, 신흥국에서의 의료 인프라의 발전, 임상 연구 활동 확대 등이 요인으로 꼽힙니다.

휴대형 경두개 자극 장치 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 19억 9,000만 달러에 달하고, CAGR은 9.9%를 나타낼 전망입니다. 예측 기간 동안의 성장 요인으로는 개별화된 뇌 건강 솔루션에 대한 주목 증가, 신경 재활 프로그램에 대한 투자 증가, 인지기능 저하를 경험하는 노인 인구 증가, 정신 웰니스 촉진을 위한 정부 시책의 확대, 외래 신경치료 센터의 확충, 휴대형 치료 기기에 대한 선호 증가 등이 있습니다. 예측 기간의 주요 동향으로는 컴팩트하고 웨어러블한 자극 시스템의 기술적 진보, 사용자 친화적인 인터페이스 설계의 개선, 멀티모달 자극 기능의 혁신, 원격 모니터링과 앱 기반의 치료 통합의 진전, 적응형 자극 알고리즘의 연구 개발, 자극 제공의 안전성과 정밀도의 향상을 들 수 있습니다.

신경질환 및 정신질환의 유병률 증가는 향후 수년간 휴대용 경두개 자극 장치 시장의 성장을 이끌 것으로 예측됩니다. 신경질환과 정신질환은 뇌와 신경계에 영향을 미치며 사고, 감정, 행동의 변화를 유발합니다. 이러한 질병 증가는 주로 만성 스트레스와 관련이 있으며, 스트레스는 뇌내 화학 물질과 신경 기능을 방해하고 정신 회복력을 감소시키고 이러한 질병에 대한 취약성을 높입니다. 휴대용 경두개 자극 장치는 특정 영역에 저강도의 전류를 흘려 뇌 활동에 영향을 주고, 신경 연결성과 기능을 향상시키고, 비침습적이고 접근하기 쉬운 방법으로 신경학적·정신의학적 질환의 증상 완화를 지원합니다. 예를 들어, 2023년 10월 영국을 거점으로 하는 각국 신경학회의 연합체인 세계신경학연합(WFN)은 현재 세계 인구의 40% 이상이 어떠한 신경질환을 경험하고 있으며, 이 수치는 2050년까지 거의 두배로 된다고 보고했습니다. 따라서 신경질환과 정신질환의 유병률 증가는 휴대용 경두개 자극 장치 시장의 확대를 촉진하고 있습니다.

휴대용 경두개 자극 장치 시장의 주요 기업은 가정용 및 임상용 모두에서 비침습적이고 사용하기 쉬운 솔루션을 제공하기 위해 경두개 직류 자극(tDCS) 장치 등의 선진적인 제품 개발에 주력하고 있습니다. 경두개 직류 자극(tDCS) 장치는 저강도 전기 자극을 표적으로 하는 뇌 영역으로 보내고, 신경 활동을 조절하고, 인지 기능을 향상시키고, 신경 질환 및 정신 질환의 관리를 지원하는 비침습적인 장비입니다. 예를 들어, 2023년 10월에는 핀란드의 의료기기 제조업체인 Sooma Oy사가 우울증이나 만성 통증 등의 증상에 대해 의사가 처방하는 신경조절 요법을 제공하도록 설계된 휴대형 tDCS 기반의 뇌자극장치 'Sooma Duo'를 발표했습니다. 이 장치는 원격으로 임상의를 통한 모니터링, 사전 설정된 전극 위치, 자동 저항 제어를 특징으로 하며, 치료 준수, 치료 효과, 가정 및 임상 환경에서 뇌 자극 요법의 접근성을 향상시킵니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

SHW
영문 목차

영문목차

The portable transcranial stimulation device is a compact and mobile unit designed to deliver targeted electrical or magnetic stimulation to the brain to influence neural activity. It improves cognitive and neurological functions through precise, non-invasive treatment. Its portable structure ensures convenience and ease of use, allowing users to receive therapy at any time and place. The device also provides consistent and controlled stimulation, supporting effective neurological outcomes.

The main product categories of portable transcranial stimulation devices include transcranial direct current stimulation (tDCS) devices, transcranial magnetic stimulation (TMS) devices, and others. Transcranial direct current stimulation (tDCS) devices are portable tools that deliver low-intensity electrical currents to specific brain regions to alter neuronal activity for therapeutic or cognitive improvement. These devices are available through both online and offline distribution channels and are applied in areas such as depression, anxiety, pain management, cognitive enhancement, and others. They are used by various end users, including hospitals and clinics, home care environments, research institutes, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The portable transcranial stimulation device market research report is one of a series of new reports from The Business Research Company that provides portable transcranial stimulation device market statistics, including portable transcranial stimulation device industry global market size, regional shares, competitors with a portable transcranial stimulation device market share, detailed portable transcranial stimulation device market segments, market trends and opportunities, and any further data you may need to thrive in the portable transcranial stimulation device industry. The portable transcranial stimulation device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The portable transcranial stimulation device market size has grown rapidly in recent years. It will grow from $1.24 billion in 2024 to $1.37 billion in 2025 at a compound annual growth rate (CAGR) of 10.2%. The growth during the historic period can be attributed to the rising prevalence of neurological disorders, increased awareness of non-invasive brain stimulation therapies, growing demand for home-based therapeutic solutions, a global rise in mental health issues, the development of healthcare infrastructure in emerging economies, and the expansion of clinical research activities.

The portable transcranial stimulation device market size is expected to see strong growth in the next few years. It will grow to $1.99 billion in 2029 at a compound annual growth rate (CAGR) of 9.9%. The growth during the forecast period can be attributed to the increasing focus on personalized brain health solutions, rising investments in neurorehabilitation programs, a growing elderly population experiencing cognitive decline, an increase in government initiatives promoting mental wellness, the expansion of outpatient neurotherapy centers, and the rising preference for portable therapeutic devices. Key trends in the forecast period include technological progress in compact and wearable stimulation systems, improvements in user-friendly interface design, innovations in multi-modal stimulation functions, advancements in remote monitoring and app-based therapy integration, research and development in adaptive stimulation algorithms, and enhancements in the safety and precision of stimulation delivery.

The increasing prevalence of neurological and psychiatric disorders is anticipated to drive the growth of the portable transcranial stimulation device market in the coming years. Neurological and psychiatric disorders affect the brain and nervous system, resulting in alterations in thinking, emotions, or behavior. The increase in these disorders is largely associated with chronic stress, which disrupts brain chemistry and neural function, reducing mental resilience and heightening vulnerability to such conditions. Portable transcranial stimulation devices influence brain activity through low-intensity electrical currents directed at specific regions, enhancing neural connectivity and function to help relieve symptoms of neurological and psychiatric disorders in a non-invasive and accessible way. For example, in October 2023, the World Federation of Neurology, a UK-based association of national neurological societies, reported that over 40% of the global population currently experiences some form of neurological condition, with this figure expected to nearly double by 2050. Therefore, the growing prevalence of neurological and psychiatric disorders is fueling the expansion of the portable transcranial stimulation device market.

Leading companies in the portable transcranial stimulation device market are emphasizing the development of advanced products such as transcranial direct current stimulation (tDCS) devices to offer non-invasive and user-friendly solutions for both home and clinical use. Transcranial direct current stimulation (tDCS) devices are non-invasive instruments that deliver low-intensity electrical currents to targeted brain regions to regulate neuronal activity, enhance cognitive functions, and support the management of neurological and psychiatric conditions. For instance, in October 2023, Sooma Oy, a Finland-based medical device manufacturer, introduced Sooma Duo, a portable tDCS-based brain stimulation device designed to provide clinician-prescribed neuromodulation therapies for conditions such as depression and chronic pain. The device features remote clinician monitoring, preset electrode positioning, and automatic resistance control, improving treatment adherence, therapeutic results, and accessibility of brain stimulation therapies in home and clinical settings.

In March 2025, Lindus Health, a UK-based contract research organization, collaborated with Sooma Medical to conduct a pivotal phase 3 clinical trial evaluating Sooma's wearable transcranial direct current stimulation (tDCS) cap, Sooma 2GEN, as a home-based treatment for major depressive disorder (MDD). This partnership aims to produce comprehensive safety and efficacy data in real-world remote conditions, expedite regulatory approval, and promote the broader commercialization of Sooma's portable brain stimulation platform. Sooma Medical is a Finland-based manufacturer of portable transcranial stimulation devices.

Major players in the portable transcranial stimulation device market are Neurocare Group AG, G.Tec Medical Engineering, Neurosoft Ltd., Neuroelectrics Barcelona S.L.U., Salvia BioElectronics B.V., Flow Neuroscience AB, Soterix Medical Inc., RPW Technology LLC, Sooma Medical Inc., Ybrain Co. Ltd., Remed Co. Ltd., Fisher Wallace Laboratories Inc., Nexalin Technology Inc., Caputron LLC, Mind Alive Inc., Ionclinics GmbH, NeuroEM Therapeutics Inc., NeuroSigma Inc., PlatoScience Inc., and TheBrainDriver GmbH.

North America was the largest region in the portable transcranial stimulation device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in portable transcranial stimulation device report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the portable transcranial stimulation device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The portable transcranial stimulation device market consists of sales of stimulation headbands, wearable stimulation caps, handheld stimulators, electrode patches, rechargeable battery packs, stimulation kits, and electrode gels. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Portable Transcranial Stimulation Device Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on portable transcranial stimulation device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for portable transcranial stimulation device ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The portable transcranial stimulation device market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Portable Transcranial Stimulation Device Market Characteristics

3. Portable Transcranial Stimulation Device Market Trends And Strategies

4. Portable Transcranial Stimulation Device Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Portable Transcranial Stimulation Device Growth Analysis And Strategic Analysis Framework

6. Portable Transcranial Stimulation Device Market Segmentation

7. Portable Transcranial Stimulation Device Market Regional And Country Analysis

8. Asia-Pacific Portable Transcranial Stimulation Device Market

9. China Portable Transcranial Stimulation Device Market

10. India Portable Transcranial Stimulation Device Market

11. Japan Portable Transcranial Stimulation Device Market

12. Australia Portable Transcranial Stimulation Device Market

13. Indonesia Portable Transcranial Stimulation Device Market

14. South Korea Portable Transcranial Stimulation Device Market

15. Western Europe Portable Transcranial Stimulation Device Market

16. UK Portable Transcranial Stimulation Device Market

17. Germany Portable Transcranial Stimulation Device Market

18. France Portable Transcranial Stimulation Device Market

19. Italy Portable Transcranial Stimulation Device Market

20. Spain Portable Transcranial Stimulation Device Market

21. Eastern Europe Portable Transcranial Stimulation Device Market

22. Russia Portable Transcranial Stimulation Device Market

23. North America Portable Transcranial Stimulation Device Market

24. USA Portable Transcranial Stimulation Device Market

25. Canada Portable Transcranial Stimulation Device Market

26. South America Portable Transcranial Stimulation Device Market

27. Brazil Portable Transcranial Stimulation Device Market

28. Middle East Portable Transcranial Stimulation Device Market

29. Africa Portable Transcranial Stimulation Device Market

30. Portable Transcranial Stimulation Device Market Competitive Landscape And Company Profiles

31. Portable Transcranial Stimulation Device Market Other Major And Innovative Companies

32. Global Portable Transcranial Stimulation Device Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Portable Transcranial Stimulation Device Market

34. Recent Developments In The Portable Transcranial Stimulation Device Market

35. Portable Transcranial Stimulation Device Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기